Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Oxygenation and Cognitive Function in Thoracoscopic Lobectomy
NCT07086911Phase 2Not yet recruiting
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of remimazolam in lung diseases. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
lung diseases
Beyond the preview
Go deeper on NCT07086911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07086911.